CAS RN: 499231-24-2
4-Morpholinecarboxylic acid, 6-chloro-3-(2-cyclopropyl-6-methylphenoxy)-4-pyridazinyl ester
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20251115 |
1mg / 5mg |
Out of stock |
8-10 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 5g, 0.05g, 0.1g, 0.25g, 1g
- Available purity: ≥95%
- Inventory rows with stock: 5
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 499231-24-2
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 5g |
≥95% |
2
In Stock
|
Shanghai |
Inquiry |
| 0.05g |
≥95% |
1
In Stock
|
Beijing |
Inquiry |
| 0.1g |
≥95% |
1
In Stock
|
Beijing |
Inquiry |
| 0.25g |
≥95% |
1
In Stock
|
Shenzhen |
Inquiry |
| 1g |
≥95% |
1
In Stock
|
Beijing |
Inquiry |
499231-24-2 / [6-chloro-3-(2-cyclopropyl-6-methylphenoxy)pyridazin-4-yl] morpholine-4-carboxylate
Standard CAS: 499231-24-2
Multi CAS: Yes
Basic Information
CAS
499231-24-2
Multi CAS
Yes
Molecular Formula
C19H20CLN3O4
Molecular Weight
389.800000
Exact Mass
389.114234
InChI
InChI=1S/C19H20ClN3O4/c1-12-3-2-4-14(13-5-6-13)17(12)27-18-15(11-16(20)21-22-18)26-19(24)23-7-9-25-10-8-23/h2-4,11,13H,5-10H2,1H3
InChIKey
BXIGJZDQFDFASM-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
27
Aromatic heavy atom count
12
Fraction Csp3
0.42
Rotatable bonds
4
H-bond acceptors
6
Molar refractivity
98.69
TPSA
73.78
LogP / Solubility
WLOGP
3.94
MLOGP
3.49
XLogP3
3.3
Consensus LogP
3.58
Log S (ESOL)
-4.8
Class (ESOL)
Slightly soluble
Log S (Ali)
-5.6
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5.94
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.3
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3